Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

JAMES WALKER FLUOLION EMULSION PACKING TYPE 2***OBSOLETE**

NFPA

PRODUCT USE

Lubricated packing, proofed packing and foil wrapped packing coils used as gland packings
in stuffing boxes of equipment such as pumps, compressors and valves.

SYNONYMS

"Fluolion Emulsion Packing Type 2 (No.463W)", "Fluolion Emulsion Packing Type 2 No.463W",
"463W Packing Type 2", "Packing Type 2 463W", "asbestos yarn packings", "asbestos, white"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

May cause CANCER.
Toxic: danger of serious damage to health by prolonged exposure through
inhalation.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Although ingestion is not thought to produce harmful effects, the material may still be damaging to the health of the individual following ingestion, especially where pre-  existing organ (e.g. liver, kidney) damage is evident. Present definitions of harmful or toxic substances are generally based on doses producing mortality (death) rather than those producing morbidity (disease, ill-health). Gastrointestinal tract discomfort may produce nausea and vomiting. In an occupational setting however, ingestion of insignificant quantities is not thought to be cause for concern.  

EYE

  Although the material is not thought to be an irritant, direct contact with the eye may produce transient discomfort characterized by tearing or conjunctival redness (as with windburn).  

SKIN

  The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  

INHALED

  The material is not thought to produce adverse health effects or irritation of the respiratory tract (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting.  

CHRONIC HEALTH EFFECTS

  There is sufficient evidence to suggest that this materialdirectly causes cancer in humans.  

  Principal route of exposure to asbestos is via inhalation of the  dust. Asbestos has shown to cause fatal lung cancers, including  mesothelioma, as well as being associated with colon, rectal, vocal-cord and  kidney cancers. Repeated exposures to asbestos can cause asbestosis, a lung-  scarring characterised by shortness of breath with exertion and possible  progression to disability and death. Asbestos fibres can accumulate in the  lungs and can be distributed to other organs in the body. Whilst large  fibres are normally quickly eliminated from the upper airways, small fibres  may remain deep in the lungs for years. Chronic health effects can occur at  any time after initial exposure, and even after exposure has ceased, and can  take months or years (as long as 7 to 50 years) to manifest themselves.  WARNING : Asbestos is classified by Worksafe as Category 1 - ESTABLISHED  HUMAN CARCINOGEN, by IARC as Group 1 - CARCINOGENIC TO HUMANS and by ACGIH  as A1 - CONFIRMED HUMAN CARCINOGEN.  Use strict occupational hygiene practices to avoid all personal contact.